Novartis (NVS - Get Report) agreed to acquire AveXis (AVXS for $8.7 billion on Monday. 

"This is squarely in the crosshairs of Biogen (BIIB - Get Report) which has that great deal with Ionis (IONS - Get Report) ," said TheStreet's founder and Action Alerts PLUS Portfolio Manager Jim Cramer.

Want exclusive investing insight from Jim Cramer? Get 24/7 access to Jim's charitable trust portfolio with a free trial to Action Alerts PLUS!

Watch all of Jim Cramer's full NYSE live shows right here: